News
Thailand’s Cannabis Policy: Embracing a Nuanced Approach for Health and Economy

(CTN News) – This is an opinion editorial by Carl K Linn, VP of Policy & Business Development at The American Journal of Cannabinoid Medicine.
I extend my best wishes in the name of Prime Minister Srettha Thavisin, Deputy Prime Minister Anutin Charnvirakul, Minister of Public Health Somsak Thepsuthin, Former Minister of Public Health Cholnan Srikaew, and members of the Thai Parliament.
As a representative of The American Journal of Endocannabinoid Medicine, I am writing to you today with renewed optimism regarding Thailand’s potential to become a global leader in responsible cannabis regulation.
In light of the recent cabinet reshuffle and Mr. Somsak Thepsuthin’s appointment as Public Health Minister, there is a critical opportunity to embrace a pragmatic approach that prioritizes public health, economic benefits, and patient well-being.
Cholnan Srikaew’s replacement by former Justice Minister Somsak Thepsuthin highlights the importance of finding a solution to the deep political and social divisions involving cannabis.
A Stalemated Debate and the Need for Compromise
As a result of the ongoing stalemate over the cannabis draft act, particularly the proposed prohibition of recreational use, it is clear that there is no consensus on how to move forward.
As a result of the Prime Minister’s public statements advocating for cannabis to be reclassified as a narcotic and the swift opposition from Deputy Prime Minister Anutin Charnvirakul, there are deep political fissures on this issue.
With its emphasis on negligible regulation or recriminalization, this all-or-nothing approach risks overlooking the potential benefits of a more nuanced regulatory approach.
There is no doubt that Dr. Cholnan Srikaew was under tremendous pressure from both pro-cannabis and anti-cannabis factions during his time as Minister of Public Health.
The influence of former Prime Minister Thaksin Shinawatra, an ardent opponent of cannabis, adds to the complexity of the situation.
A New Health Minister and the Road Ahead
As Health Minister, Mr. Somsak Thepsuthin must navigate a minefield of competing interests. While his prior support for decriminalization is encouraging, he does not possess a strong understanding of the medical aspects of cannabis.
The Limitations of the Binary: Beyond “Anything Goes” or Recriminalization
An all-or-nothing approach to cannabis regulation, such as the one in the Cannabis Act, is exemplified by the current debate surrounding the recreational use of cannabis.
Cannabis recriminalization disregards not only the growing body of evidence regarding its therapeutic potential but also fails to address the thriving unregulated market, potentially further obliterating it.
The Power of “Both/And”: A Two-Tiered Expansive Medical Cannabis Solution
The Expansive Medical Cannabis proposal I recently outlined allows Thailand to take a more nuanced approach: a “both/and” approach. In this framework, medical cannabis regulations are prioritized while acknowledging the realities of existing demand for the product. The proposal is summarized as follows:
-
A Two-Tiered Access System:
-
Tier 1: Expanding Access through Licensed Dispensaries:
-
In this tier, existing dispensaries can be repurposed as medical cannabis dispensaries under a clear regulatory framework to streamline the transition. In addition to offering patients a wide range of cannabis products based on their needs, trained staff can guide them toward appropriate cannabis products as usual.
-
Opponents may argue that an open system poses a risk of misuse. Nevertheless, strict regulations, including age verification, clear dosage guidelines, and aggressive educational environments, can mitigate the risks. It is also imperative to promote responsible use through public education campaigns.
-
A key benefit of this tier is that patients are empowered to explore the benefits of cannabis for their specific conditions by gaining greater control over their treatment journey. Medicinal cannabis dispensaries may be required to present themselves as clinics, offering individualized learning centers with infographics on the walls, peer-reviewed cannabis information online, and even filling prescriptions.
-
-
Tier 2: Prescription-Based Access for Complex Conditions:
-
As part of this tier, patients with complex medical conditions may require ongoing physician supervision, as well as potentially high-THC formulations or specialized cannabis products.
-
This ensures continued doctor involvement for such cases and signals to employees that this patient should not be exposed to other products or enticed to purchase anything not recommended by his or her healthcare professional.
-
The Thai Advantage: Leveraging Traditional Wisdom and Modern Science
There has been a recent explosion in research into the endocannabinoid system (ECS), which provides scientific evidence for the therapeutic effects observed in Thai Traditional Medicine (TTM) practices that have used cannabis for centuries.
In the future, medical cannabis treatments will seamlessly integrate with established TTM practices, providing patients with a truly holistic approach to their medical care. This would strengthen Thailand’s position as a global leader in medical tourism while also fostering innovation within the medical cannabis industry, resulting in the development of innovative treatment options combining traditional practices and modern scientific understanding.
A Call for Open Dialogue and Evidence-Based Policymaking
As Thailand prepares to become a global cannabis innovation hub, the next few months will be crucial for Thailand’s cannabis policy. For Thailand to thrive as a global cannabis innovation hub, I urge you to adhere to the following principles:
-
Open Dialogue: To reach a solution that addresses all concerns, policymakers, medical professionals, industry stakeholders, and the general public must communicate openly and transparently.
-
Evidence-Based Policymaking: Ensure that regulatory decisions are based on the most recent research regarding cannabis’s therapeutic potential and potential risks.
-
A Patient-Centered Approach: We prioritize patients’ needs and well-being. Our two-tiered Expansive Medical Cannabis system provides patients with more control over their treatment journey while ensuring patient oversight.
A brighter future for Thailand cannabis
Thailand can unlock the full potential of cannabis by adopting the Expansive Medical Cannabis proposal:
-
Becoming a Global Leader in Responsible Cannabis Regulation: Thailand can serve as a model for other countries considering cannabis legalization, demonstrating a commitment to safety, accessibility, and responsible innovation.
-
Cultivating a Flourishing Medical Cannabis Sector: Repurposed recreational dispensaries can become hubs for high-quality medical cannabis, fostering competition and innovation within the medical cannabis industry. As a result, Thai will be able to provide patients with a greater variety of safe and effective cannabis products, leading to increased economic growth and job opportunities.
-
A Beacon of Innovation in Medical Cannabis Treatment: Thailand can become a leader in the development of cannabis-based treatment options by integrating traditional practices with modern scientific understanding. This will benefit Thai patients and international medical tourists, further boosting Thailand’s economy.
-
Emerging as a Global Medical Tourism Destination: Combined with Thailand’s established tradition of Traditional Medicine and its reputation for hospitality, a robust medical cannabis program can generate a thriving medical tourism market. Due to Thailand’s cutting-edge cannabis treatments and holistic approach to healthcare, patients from around the world will be attracted to the country.
It is a pragmatic, preventive, patient-centered proposal emphasizing public health, economic growth, and responsible innovation as priorities for the Expansive Medical Cannabis proposal.
By leveraging existing infrastructure, it empowers patients to take greater control of their treatment journeys and fosters a robust medical cannabis industry.
By embracing this framework, Thailand will be able to seize this historic opportunity to become a global leader in the responsible and innovative use of cannabis.
You, the esteemed leaders of Thailand, should encourage open dialogue, prioritize evidence-based policymaking, and put patients’ needs at the forefront of this critical conversation. As a result of our collaboration, Thailand’s citizens and its position on the global stage can benefit from cannabis’s vast potential.

News
Google’s Search Dominance Is Unwinding, But Still Accounting 48% Search Revenue

Google is so closely associated with its key product that its name is a verb that signifies “search.” However, Google’s dominance in that sector is dwindling.
According to eMarketer, Google will lose control of the US search industry for the first time in decades next year.
Google will remain the dominant search player, accounting for 48% of American search advertising revenue. And, remarkably, Google is still increasing its sales in the field, despite being the dominating player in search since the early days of the George W. Bush administration. However, Amazon is growing at a quicker rate.
Google’s Search Dominance Is Unwinding
Amazon will hold over a quarter of US search ad dollars next year, rising to 27% by 2026, while Google will fall even more, according to eMarketer.
The Wall Street Journal was first to report on the forecast.
Lest you think you’ll have to switch to Bing or Yahoo, this isn’t the end of Google or anything really near.
Google is the fourth-most valued public firm in the world. Its market worth is $2.1 trillion, trailing just Apple, Microsoft, and the AI chip darling Nvidia. It also maintains its dominance in other industries, such as display advertisements, where it dominates alongside Facebook’s parent firm Meta, and video ads on YouTube.
To put those “other” firms in context, each is worth more than Delta Air Lines’ total market value. So, yeah, Google is not going anywhere.
Nonetheless, Google faces numerous dangers to its operations, particularly from antitrust regulators.
On Monday, a federal judge in San Francisco ruled that Google must open up its Google Play Store to competitors, dealing a significant blow to the firm in its long-running battle with Fortnite creator Epic Games. Google announced that it would appeal the verdict.
In August, a federal judge ruled that Google has an illegal monopoly on search. That verdict could lead to the dissolution of the company’s search operation. Another antitrust lawsuit filed last month accuses Google of abusing its dominance in the online advertising business.
Meanwhile, European regulators have compelled Google to follow tough new standards, which have resulted in multiple $1 billion-plus fines.

Pixa Bay
Google’s Search Dominance Is Unwinding
On top of that, the marketplace is becoming more difficult on its own.
TikTok, the fastest-growing social network, is expanding into the search market. And Amazon has accomplished something few other digital titans have done to date: it has established a habit.
When you want to buy anything, you usually go to Amazon, not Google. Amazon then buys adverts to push companies’ products to the top of your search results, increasing sales and earning Amazon a greater portion of the revenue. According to eMarketer, it is expected to generate $27.8 billion in search revenue in the United States next year, trailing only Google’s $62.9 billion total.
And then there’s AI, the technology that (supposedly) will change everything.
Why search in stilted language for “kendall jenner why bad bunny breakup” or “police moving violation driver rights no stop sign” when you can just ask OpenAI’s ChatGPT, “What’s going on with Kendall Jenner and Bad Bunny?” in “I need help fighting a moving violation involving a stop sign that wasn’t visible.” Google is working on exactly this technology with its Gemini product, but its success is far from guaranteed, especially with Apple collaborating with OpenAI and other businesses rapidly joining the market.
A Google spokeswoman referred to a blog post from last week in which the company unveiled ads in its AI overviews (the AI-generated text that appears at the top of search results). It’s Google’s way of expressing its ability to profit on a changing marketplace while retaining its business, even as its consumers steadily transition to ask-and-answer AI and away from search.
Google has long used a single catchphrase to defend itself against opponents who claim it is a monopoly abusing its power: competition is only a click away. Until recently, that seemed comically obtuse. Really? We are going to switch to Bing? Or Duck Duck Go? Give me a break.
But today, it feels more like reality.
Google is in no danger of disappearing. However, every highly dominating company faces some type of reckoning over time. GE, a Dow mainstay for more than a century, was broken up last year and is now a shell of its previous dominance. Sears declared bankruptcy in 2022 and is virtually out of business. US Steel, long the foundation of American manufacturing, is attempting to sell itself to a Japanese corporation.
SOURCE | CNN
News
The Supreme Court Turns Down Biden’s Government Appeal in a Texas Emergency Abortion Matter.

(VOR News) – A ruling that prohibits emergency abortions that contravene the Supreme Court law in the state of Texas, which has one of the most stringent abortion restrictions in the country, has been upheld by the Supreme Court of the United States. The United States Supreme Court upheld this decision.
The justices did not provide any specifics regarding the underlying reasons for their decision to uphold an order from a lower court that declared hospitals cannot be legally obligated to administer abortions if doing so would violate the law in the state of Texas.
Institutions are not required to perform abortions, as stipulated in the decree. The common populace did not investigate any opposing viewpoints. The decision was made just weeks before a presidential election that brought abortion to the forefront of the political agenda.
This decision follows the 2022 Supreme Court ruling that ended abortion nationwide.
In response to a request from the administration of Vice President Joe Biden to overturn the lower court’s decision, the justices expressed their disapproval.
The government contends that hospitals are obligated to perform abortions in compliance with federal legislation when the health or life of an expectant patient is in an exceedingly precarious condition.
This is the case in regions where the procedure is prohibited. The difficulty hospitals in Texas and other states are experiencing in determining whether or not routine care could be in violation of stringent state laws that prohibit abortion has resulted in an increase in the number of complaints concerning pregnant women who are experiencing medical distress being turned away from emergency rooms.
The administration cited the Supreme Court’s ruling in a case that bore a striking resemblance to the one that was presented to it in Idaho at the beginning of the year. The justices took a limited decision in that case to allow the continuation of emergency abortions without interruption while a lawsuit was still being heard.
In contrast, Texas has been a vocal proponent of the injunction’s continued enforcement. Texas has argued that its circumstances are distinct from those of Idaho, as the state does have an exemption for situations that pose a significant hazard to the health of an expectant patient.
According to the state, the discrepancy is the result of this exemption. The state of Idaho had a provision that safeguarded a woman’s life when the issue was first broached; however, it did not include protection for her health.
Certified medical practitioners are not obligated to wait until a woman’s life is in imminent peril before they are legally permitted to perform an abortion, as determined by the state supreme court.
The state of Texas highlighted this to the Supreme Court.
Nevertheless, medical professionals have criticized the Texas statute as being perilously ambiguous, and a medical board has declined to provide a list of all the disorders that are eligible for an exception. Furthermore, the statute has been criticized for its hazardous ambiguity.
For an extended period, termination of pregnancies has been a standard procedure in medical treatment for individuals who have been experiencing significant issues. It is implemented in this manner to prevent catastrophic outcomes, such as sepsis, organ failure, and other severe scenarios.
Nevertheless, medical professionals and hospitals in Texas and other states with strict abortion laws have noted that it is uncertain whether or not these terminations could be in violation of abortion prohibitions that include the possibility of a prison sentence. This is the case in regions where abortion prohibitions are exceedingly restrictive.
Following the Supreme Court’s decision to overturn Roe v. Wade, which resulted in restrictions on the rights of women to have abortions in several Republican-ruled states, the Texas case was revisited in 2022.
As per the orders that were disclosed by the administration of Vice President Joe Biden, hospitals are still required to provide abortions in cases that are classified as dire emergency.
As stipulated in a piece of health care legislation, the majority of hospitals are obligated to provide medical assistance to patients who are experiencing medical distress. This is in accordance with the law.
The state of Texas maintained that hospitals should not be obligated to provide abortions throughout the litigation, as doing so would violate the state’s constitutional prohibition on abortions. In its January judgment, the 5th United States Circuit Court of Appeals concurred with the state and acknowledged that the administration had exceeded its authority.
SOURCE: AP
SEE ALSO:
Could Last-Minute Surprises Derail Kamala Harris’ Campaign? “Nostradamus” Explains the US Poll.
News
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli, To repay $6.4 Million

Washington — The Supreme Court rejected Martin Shkreli’s appeal on Monday, after he was branded “Pharma Bro” for raising the price of a lifesaving prescription.
Martin appealed a decision to repay $64.6 million in profits he and his former company earned after monopolizing the pharmaceutical market and dramatically raising its price. His lawyers claimed the money went to his company rather than him personally.
The justices did not explain their reasoning, as is customary, and there were no notable dissents.
Prosecutors, conversely, claimed that the firm had promised to pay $40 million in a settlement and that because Martin orchestrated the plan, he should be held accountable for returning profits.
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli
Martin was also forced to forfeit the Wu-Tang Clan’s unreleased album “Once Upon a Time in Shaolin,” which has been dubbed the world’s rarest musical album. The multiplatinum hip-hop group auctioned off a single copy of the record in 2015, stipulating that it not be used commercially.
Shkreli was convicted of lying to investors and defrauding them of millions of dollars in two unsuccessful hedge funds he managed. Shkreli was the CEO of Turing Pharmaceuticals (later Vyera), which hiked the price of Daraprim from $13.50 to $750 per pill after acquiring exclusive rights to the decades-old medicine in 2015. It cures a rare parasite condition that affects pregnant women, cancer patients, and HIV patients.
He defended the choice as an example of capitalism in action, claiming that insurance and other programs ensured that those in need of Daraprim would eventually receive it. However, the move prompted criticism, from the medical community to Congress.
Supreme Court Rejects Appeal From ‘Pharma Bro’ Martin Shkreli
Attorney Thomas Huff said the Supreme Court’s Monday ruling was upsetting, but the high court could still overturn a lower court judgment that allowed the $64 million penalty order even though Shkreli had not personally received the money.
“If and when the Supreme Court does so, Mr. Shkreli will have a strong argument for modifying the order accordingly,” he told reporters.
Shkreli was freed from prison in 2022 after serving most of his seven-year sentence.
SOURCE | AP
-
News4 years ago
Let’s Know About Ultra High Net Worth Individual
-
Entertainment2 years ago
Mabelle Prior: The Voice of Hope, Resilience, and Diversity Inspiring Generations
-
Health4 years ago
How Much Ivermectin Should You Take?
-
Tech2 years ago
Top Forex Brokers of 2023: Reviews and Analysis for Successful Trading
-
Lifestyles3 years ago
Aries Soulmate Signs
-
Movies2 years ago
What Should I Do If Disney Plus Keeps Logging Me Out of TV?
-
Health3 years ago
Can I Buy Ivermectin Without A Prescription in the USA?
-
Learning3 years ago
Virtual Numbers: What Are They For?